Borrelia burgdorferi Osp B Antibodies

Santa Cruz Biotechnology delivers a wide array of Borrelia burgdorferi Osp B monoclonal antibodies for research in understanding Lyme disease and its causative agent. Borrelia burgdorferi Osp B Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Osp B, or outer surface protein B, plays a crucial role in the pathogenesis of Borrelia burgdorferi, facilitating the bacterium's survival and persistence within the host. Understanding the function of Osp B is essential for developing effective diagnostics and therapeutics for Lyme disease. The study of Borrelia burgdorferi Osp B is vital for advancing our knowledge of host-pathogen interactions and the immune response to infection. Research into Osp B continues to reveal new insights about bacterial adaptation and survival mechanisms. Investigating the molecular mechanisms of Osp B can lead to breakthroughs in treatment strategies. The relationship between Osp B and host immune responses remains an active area of investigation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of Lyme disease pathogenesis and potential therapeutic approaches.